[2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate

C30H41N3O5 — CID 59809805

IUPAC[2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate
SMILESCCCCn1ncc2c1C=C1CC[C@@H]3[C@H]([C@@H](O)C[C@@]4(C)[C@H]3C[C@H]3OC(C)=N[C@]34C(=O)COC(C)=O)[C@@]1(C)C2
InChIInChI=1S/C30H41N3O5/c1-6-7-10-33-23-11-20-8-9-21-22-12-26-30(32-17(2)38-26,25(36)16-37-18(3)34)29(22,5)14-24(35)27(21)28(20,4)13-19(23)15-31-33/h11,15,21-22,24,26-27,35H,6-10,12-14,16H2,1-5H3/t21-,22-,24-,26+,27+,28-,29-,30+/m0/s1
InChIKeyWSEPLXFOHNKFQV-WUCWLWNRSA-N
MW523.67 g/mol
LogP4.13
Rot. Bonds6

About [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate

[2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate (PubChem CID 59809805) has the molecular formula C30H41N3O5 and a molecular weight of 523.67 g/mol. Its IUPAC name is [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate.

Molecular Properties

Compound Name[2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate
PubChem CID59809805
Molecular FormulaC30H41N3O5
Molecular Weight523.67 g/mol
Exact Mass523.30
IUPAC Name[2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate
SMILESCCCCn1ncc2c1C=C1CC[C@@H]3[C@H]([C@@H](O)C[C@@]4(C)[C@H]3C[C@H]3OC(C)=N[C@]34C(=O)COC(C)=O)[C@@]1(C)C2
InChIInChI=1S/C30H41N3O5/c1-6-7-10-33-23-11-20-8-9-21-22-12-26-30(32-17(2)38-26,25(36)16-37-18(3)34)29(22,5)14-24(35)27(21)28(20,4)13-19(23)15-31-33/h11,15,21-22,24,26-27,35H,6-10,12-14,16H2,1-5H3/t21-,22-,24-,26+,27+,28-,29-,30+/m0/s1
InChIKeyWSEPLXFOHNKFQV-WUCWLWNRSA-N
XLogP4.13
TPSA103.01 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500523.67
LogP ≤ 54.13
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate?
The IUPAC name of [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate (CID 59809805) is [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate.
What is the SMILES notation for [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate?
The canonical SMILES for [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate is CCCCn1ncc2c1C=C1CC[C@@H]3[C@H]([C@@H](O)C[C@@]4(C)[C@H]3C[C@H]3OC(C)=N[C@]34C(=O)COC(C)=O)[C@@]1(C)C2.
What is the InChIKey of [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate?
The InChIKey is WSEPLXFOHNKFQV-WUCWLWNRSA-N. The full InChI is InChI=1S/C30H41N3O5/c1-6-7-10-33-23-11-20-8-9-21-22-12-26-30(32-17(2)38-26,25(36)16-37-18(3)34)29(22,5)14-24(35)27(21)28(20,4)13-19(23)15-31-33/h11,15,21-22,24,26-27,35H,6-10,12-14,16H2,1-5H3/t21-,22-,24-,26+,27+,28-,29-,30+/m0/s1.
What are the key properties of [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate?
[2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate has a molecular weight of 523.67 g/mol, XLogP of 4.13, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(1S,2R,13S,14S,16R,20S,21S,23S)-7-butyl-23-hydroxy-2,18,21-trimethyl-17-oxa-6,7,19-triazahexacyclo[11.10.0.02,10.04,8.014,21.016,20]tricosa-4(8),5,9,18-tetraen-20-yl]-2-oxoethyl] acetate is sourced from PubChem (CID 59809805), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).